Sort
30,917 grants matching “tumor microenvironment”
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy
$364,284Serge Y Fuchs · University Of Pennsylvania · R01 · FY2022 · CA
Reactivation of type I interferon pathway to increase the efficacy of chemotherapy
$364,284Serge Y Fuchs · University Of Pennsylvania · R01 · FY2023 · CA
Biological Indicators of Racial Disparity in Ameloblastoma Recurrence
$364,284Sunday O Akintoye · University Of Pennsylvania · R01 · FY2023 · CA
Effectively Targeting Notch in Hypoxic Brain Tumor Cells
$364,276Charles George Eberhart · Johns Hopkins University · R01 · FY2013 · NS
Fast interference-based super-resolution microscope for cancer mechanobiology
$364,273Warren R Zipfel · Cornell University · R33 · FY2015 · CA
Role of Hypoxia-Induced miR-210 in Tumor Metabolism
$364,233Mircea Ivan · Indiana University Indianapolis · R01 · FY2011 · CA
Defining the determinants of response and resistance to therapy for Richter's Syndrome
$364,213Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Rice Bran Microbial Metabolism for Colon Chemoprevention
$364,133Elizabeth P Ryan · Colorado State University · R01 · FY2016 · CA
Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology
$364,129Kumar Pichumani · Methodist Hospital Research Institute · R01 · FY2025 · CA
Quantitation of nutrient metabolism in brain tumor patients using advanced 13C isotopomer technology
$364,129Kumar Pichumani · Methodist Hospital Research Institute · R01 · FY2023 · CA
Novel Target(s) in the Radiosensitization of Pancreatic Cancer
$364,128Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2016 · CA
Novel Target(s) in the Radiosensitization of Pancreatic Cancer
$364,127Surinder Kumar Batra · University Of Nebraska Medical Center · P50 · FY2014 · CA
Glycobiology of Human Medulloblastoma
$364,080Children'S Research Institute · R01 · FY2005 · CA
Glycobiology of Human Medulloblastoma
$364,080Children'S Research Institute · R01 · FY2004 · CA
Glycobiology of Human Medulloblastoma
$364,080Children'S Research Institute · R01 · FY2003 · CA
Glycobiology of Human Medulloblastoma
$364,080Children'S Research Institute · R01 · FY2002 · CA
Proteomic, Glycomic and Autoantibody Lung Cancer Biomarker Validation
$364,038Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2015 · CA
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
$364,007Paul Nghiem · University Of Washington · P01 · FY2019 · CA
Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancer
$363,999Kurt A Schalper · Yale University · R01 · FY2024 · CA
Initiation and evolution of the ovarian cancer microenvironment
$363,981Jose R Conejo-Garcia · Wistar Institute · R01 · FY2011 · CA
Multi-Scale Engineering of Heterogeneity in the Host-Aware Synthetic Gene Circuits
$363,968Xiaojun Tian · Arizona State University-Tempe Campus · R35 · FY2024 · GM
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$363,916Anupriya Agarwal · Oregon Health & Science University · U54 · FY2020 · CA
Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML
$363,916Anupriya Agarwal · Oregon Health & Science University · U54 · FY2021 · CA
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$363,913Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2023 · NS
Engineered and Encapsulated Stem Cells for Resected Brain Tumors
$363,913Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2022 · NS